גמציטבין "אבווה" 10 מ"ג/1 מ"ל

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

GEMCITABINE AS HYDROCHLORIDE 10 MG

Commercializzato da:

PHARMALOGIC LTD

Codice ATC:

L01BC05

Forma farmaceutica:

CONCENTRATE FOR SOLUTION FOR INFUSION

Via di somministrazione:

I.V

Prodotto da:

EBEWE PHARMA GES.M.B.H NFG. KG, AUSTRIA

Gruppo terapeutico:

GEMCITABINE

Indicazioni terapeutiche:

Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Data dell'autorizzazione:

2010-06-01